🇺🇸 Nicotinic acid (niacin) in United States
12 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 12
Most-reported reactions
- Liver Disorder — 2 reports (16.67%)
- Pyrexia — 2 reports (16.67%)
- Aggression — 1 report (8.33%)
- Alanine Aminotransferase Increased — 1 report (8.33%)
- Aspartate Aminotransferase Increased — 1 report (8.33%)
- Blood Urine Present — 1 report (8.33%)
- Confusional State — 1 report (8.33%)
- Diarrhoea — 1 report (8.33%)
- Haemorrhagic Diathesis — 1 report (8.33%)
- Hepatic Lesion — 1 report (8.33%)
Other Cardiovascular approved in United States
Frequently asked questions
Is Nicotinic acid (niacin) approved in United States?
Nicotinic acid (niacin) does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Nicotinic acid (niacin) in United States?
Charite University, Berlin, Germany is the originator. The local marketing authorisation holder may differ — check the official source linked above.